1. Home
  2. KLAC vs NVS Comparison

KLAC vs NVS Comparison

Compare KLAC & NVS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo KLA Corporation

KLAC

KLA Corporation

HOLD

Current Price

$242.93

Market Cap

186.0B

Sector

Technology

ML Signal

HOLD

Logo Novartis AG

NVS

Novartis AG

HOLD

Current Price

$150.30

Market Cap

286.5B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
KLAC
NVS
Founded
1975
1895
Country
United States
Switzerland
Employees
N/A
75267
Industry
Electronic Components
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
186.0B
286.5B
IPO Year
1994
N/A

Fundamental Metrics

Financial Performance
Metric
KLAC
NVS
Price
$242.93
$150.30
Analyst Decision
Buy
Hold
Analyst Count
19
5
Target Price
$1,651.00
$144.00
AVG Volume (30 Days)
3.1M
1.6M
Earning Date
04-29-2026
04-28-2026
Dividend Yield
0.42%
2.16%
EPS Growth
49.75
N/A
EPS
26.26
N/A
Revenue
N/A
N/A
Revenue This Year
$12.45
$2.30
Revenue Next Year
$22.33
$5.27
P/E Ratio
$9.10
$23.13
Revenue Growth
N/A
N/A
52 Week Low
$236.00
$112.34
52 Week High
$2,431.29
$170.46

Technical Indicators

Market Signals
Indicator
KLAC
NVS
Relative Strength Index (RSI) 22.61 52.60
Support Level N/A $149.49
Resistance Level $1,179.40 $152.55
Average True Range (ATR) 104.98 2.16
MACD -229.52 0.38
Stochastic Oscillator 0.19 67.71

Price Performance

Historical Comparison
KLAC
NVS

About KLAC KLA Corporation

KLA is one of the largest semiconductor wafer fabrication equipment, or WFE, manufacturers in the world. It specializes in the market segment of semiconductor process control, wherein machines inspect semiconductor wafers during research and development and manufacturing for defects and verify precise measurements. In this section of the market, KLA holds a majority share. It also has a small exposure to the etch and deposition segments of the WFE market. It counts as top customers the largest chipmakers in the world, including TSMC and Samsung.

About NVS Novartis AG

Novartis develops and manufactures innovative drugs. Key areas of drug development are oncology, immunology, neuroscience, respiratory, and cardiovascular, renal, and metabolic. It also has an established medicines business, which includes off-patent franchises. The company sells its products globally, with the United States constituting close to one-third of total revenue.

Share on Social Networks: